Featured Story | By Nick Paul Taylor Merck has secured an exclusive option to license Symvivo’s bacTRL platform for use in oral vaccine delivery. The research collaboration positions Merck to evaluate a technology that uses engineered bacteria to deliver genetic material. read more |
| |
|---|
|
Top Stories By Nick Paul Taylor A phase 3 clinical trial of an extended-release formulation of the antipsychotic drug risperidone has met its primary endpoint. The study boosts Teva’s efforts to establish a presence in the market for long-acting injectable treatments for schizophrenia. read more By Nick Paul Taylor Translate Bio is aiming to deliver data on the first clinical-stage nebulized mRNA therapy early in the second quarter. The biotech set the target after the phase 1/2 cystic fibrosis clinical trial completed enrollment and dosing for the interim analysis. read more By Nick Paul Taylor U.K. physicians have begun clinical development of a nasal spray designed to prevent infection with the coronavirus and treat mild to moderate cases of COVID-19. The spray delivers nitric oxide into the nasal passages to destroy the virus at a site it uses to enter the body and begin replicating. read more By Arlene Weintraub Interferon increases levels of the cell surface protein ACE2, which serves as the entry point for COVID-19, raising concerns that Synairgen and others developing inhaled interferon-based treatments might ultimately fail. Now, a U.K. team has discovered interferon only raises levels of a short form of ACE2 that may actually be protective. read more Resources Sponsored By: Polpharma Biologics Innovative cell lines and early process development are critical to generate a high producing cell lines alongside a USP strategy to meet high quality standards. Sponsored By: Blue Matter Biopharma companies in rare diseases: How to maximize the odds of success by becoming a valued member of the unique “rare disease ecosystem.” Sponsored by: Metabolon Learn six ways metabolomics provides greater confidence, higher success rates and complements the work of your in-house teams for your drug development pipeline. Sponsored by: Covance Download the whitepaper to learn how your safety organization can implement automation technologies to enable process and cost efficiencies, improve resource allocation and ensure compliance and quality. Sponsored By: BBK Worldwide The BBK Worldwide Study Voices 2020 survey gives voice to the healthcare consumer in the wake of COVID-19 and reveals important insights for clinical trial enrollment and engagement. Sponsored by: Rousselot This infographic describes the benefits of GelMA in various biomedical applications and how X-Pure® GelMA can help you in your developments. Sponsored by: Aldevron Gene and cell therapy organizations are asked to balance the need for rapid clinical progression and stringent quality expectations throughout development. In this document, Aldevron provides an in-depth look at preparing for plasmid manufacturing based on our years of experience. Sponsored By: Outer Edge Technology A sound Cloud Strategy provides the flexibility and tools businesses need to quickly adapt and operate securely in an ever-changing remote work environment. Learn how your company can cost-effectively empower its employees to be productive and secure while working remotely. Sponsored by: Catalent Learn about drug product process development challenges and risks, the difference between innovator and biosimilar drug product process development, and more during the drug product process development phase. Sponsored by: Catalent Learn about proven strategies for a successful product launch, including cross-functional team collaboration, risk management and using the right project management tools. Sponsored by: Catalent This eBook provides insights on key approaches and considerations for preparing your drug development program for long-term success. Sponsored by: Catalent In this webinar, pharmaceutical scientists present real-life examples of challenges they’ve overcome in the transfer of oral small molecules from a dedicated early-phase development site to a dedicated late-phase manufacturing site. Sponsored by: Catalent Get insights on key considerations for a successful tech transfer process for manufacturing a biologic drug product, including a case study on overcoming challenges in a process transfer for a sterile diluent. Sponsored by: Catalent In a BioPharma Dive industry survey, planning and forecasting were identified as top concerns for trial sponsors. In response to this need, the CSM team at Catalent has developed a methodology for identifying, evaluating, and proactively managing the inherent risks involved in clinical trial supply chain management. | 
